Nonsurgical Management of Primary Cholangiocarcinoma. Retrospective Analysis of 40 Cases
Overview
Authors
Affiliations
Forty patients with cholangiocarcinoma (23 men, 17 women) underwent nonsurgical palliative biliary drainage over a period of 12 years. All were surgically unfit or had unresectable disease. All were jaundiced at presentation with a mean serum bilirubin of 11.5 +/- 1.9 mg/dl. Thirty patients (75%) had hilar obstruction. Twenty-eight were drained percutaneously, three endoscopically and nine by a combined endoscopic and percutaneous procedure. Technical success was 97.5%. Final mean bilirubin was 1.5 +/- 0.4 mg/dl. Minor complications occurred in 10 (25%) patients, and major complications in four (10%). Procedure-related mortality was 2.5% with a 30-day mortality of 7.5%. Mean survival was 8.2 +/- 0.5 months. Stent changes were required in eight patients. In patients with inoperable or unresectable cholangiocarcinoma, percutaneous or endoscopic biliary drainage offers effective palliation.
Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma.
Bhudhisawasdi V, Muisuk K, Areejitranusorn P, Kularbkaew C, Khampitak T, Saeseow O J Cancer Res Clin Oncol. 2003; 130(2):87-92.
PMID: 14648209 DOI: 10.1007/s00432-003-0515-x.
Diagnosis, Staging, and Treatment of Cholangiocarcinoma.
Yoon J, Gores G Curr Treat Options Gastroenterol. 2003; 6(2):105-112.
PMID: 12628069 DOI: 10.1007/s11938-003-0011-z.
Tannapfel A, Weinans L, Geissler F, Schutz A, Katalinic A, Kockerling F Dig Dis Sci. 2000; 45(2):317-24.
PMID: 10711445 DOI: 10.1023/a:1005412626515.
Zidi S, Prat F, Le Guen O, RONDEAU Y, Pelletier G Gut. 1999; 46(1):103-6.
PMID: 10601064 PMC: 1727781. DOI: 10.1136/gut.46.1.103.
Nomura T, Shirai Y, Hatakeyama K Dig Dis Sci. 1999; 44(3):542-6.
PMID: 10080147 DOI: 10.1023/a:1026653306735.